Literature DB >> 32390641

Motor Dysfunction as a Prodrome of Parkinson's Disease.

Fernando Alarcón1, Juan-Carlos Maldonado2, Miguel Cañizares1, José Molina1, Alastair J Noyce3,4, Andrew J Lees3,4.   

Abstract

BACKGROUND: Recognition of motor signs in the prodromal stage could help identify those at risk of developing Parkinson's disease (PD).
OBJECTIVE: This study identified motor symptoms and signs in individuals suspected of having PD but who did not have a progressive reduction in the speed and amplitude of finger tapping or other physical signs indicative of bradykinesia.
METHODS: 146 patients, who had symptoms or signs suggestive of PD, were serially evaluated by a movement disorder specialist, using the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III and video recordings. If the patients 'converted' to PD during follow-up, they were categorized as cases and compared with those who did not meet PD criteria during follow-up (non-cases).
RESULTS: The 82 cases were more likely to have action dystonia or postural/action/rest tremor of a limb (OR 2.8; 95% CI 1.1-7.1; p = 0.02), a reduced blink rate at rest (OR 2.3; 95% CI 1.2-4.6; p = 0.01), anxiety (OR 8.9; 95% CI 2.6-31.1; p < 0.001), depression (OR 7.0; 95% CI 2.9-17.2; p < 0.001), or a frozen shoulder (OR 3.1; 95% CI 1.6-6.2) than the 64 'non-cases'.A reduction of the fast blink rate was common in patients who met the criteria for PD (p < 0.001).
CONCLUSIONS: This study emphasizes that motor dysfunction is a component of the clinical prodrome seen in some patients with PD.

Entities:  

Keywords:  Parkinson’s disease; motor dysfunction; prodrome

Year:  2020        PMID: 32390641     DOI: 10.3233/JPD-191851

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  1 in total

Review 1.  The Effect of Cerebellar rTMS on Modulating Motor Dysfunction in Neurological Disorders: a Systematic Review.

Authors:  Yifei Xia; Mingqi Wang; Yulian Zhu
Journal:  Cerebellum       Date:  2022-08-26       Impact factor: 3.648

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.